EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC 4.0

Expressions of type I-III interferons in Sjögren's syndrome and non-Sjögren's dry eye

Nan Su, Lei Jiang, Yanpeng Wang, Yanping Dong, Yanjuan Yong, Kan Yang, Shixiong Gao

Ophthalmic Research · 2024

DOI: 10.1159/000540295 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Ophthalmic Research, 2024. Verfasst von Nan Su und 6 weiteren Autor:innen. Beteiligte Einrichtung: Eye families, The First People's Hospital of Lanzhou City, Lanzhou, China. Hauptthemen laut MEDLINE: Dry Eye Syndromes, Interferons, Sjogren's Syndrome. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Systemic implications create a critical need for identification of dry eye patients with Sjögren syndrome (SS). Herein, we aim to determine expressions of type I-III interferons (IFNs) in dry eye patients with or without underlying SS and their differential diagnosis.

Methods

A prospective, observational, case-control study was performed on 140 dry eye patients among which 78 patients were diagnosed with SS. Clinical evaluations included ELISA detections of serum type I IFN (IFN-α and IFN-β, type II IFN (IFN-γ), and type III IFN (IFN-λ1/IL-29, IFN-λ2/IL-28, and IFN-λ3/IL-28B), as well as reporter cell assay for serum type I IFN activity.

Results

The serum levels of IFN-α and IFN-β were notably higher in dry eye patients with SS than those without underlying SS (p < 0.0001). The functional assay for serum type I IFN activity showed the mean summed scores in dry eye patients with SS were remarkably increased compared to those without underlying SS (p < 0.0001). The serum levels of IFN-γ and IFN-λ1/IL-29 seemed higher in dry eye patients with SS than those without underlying SS (p < 0.0001). The serum levels of type I IFN (IFN-α combined with IFN-β), type II IFN (IFN-γ level), and type III IFN (IFN-λ1/IL-29) used as a test to predict underlying SS among dry eye patients produced an AUC of 0.86, 0.73, and 0.94, respectively.

Conclusion

Serum levels of type I-III IFNs, especially IFN-α, IFN-β, and IFN-λ1/IL-29, may serve as a useful biomarker for identification of SS dry eye from non-SS dry eye.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dry Eye SyndromesInterferonsSjogren's SyndromeAdultAgedFemaleHumansMaleMiddle AgedBiomarkersCase-Control StudiesEnzyme-Linked Immunosorbent AssayInterferon Type IProspective StudiesROC CurveDiagnosis, Differential

Stichwörter der Autor:innen

DiagnosisDry eye diseaseInterferonSjögren syndrome

Substanzen

BiomarkersInterferon Type IInterferons

Autor:innen und Institutionen

  • Eye families, The First People's Hospital of Lanzhou City, Lanzhou, China.
  • Department of Anesthesiology, The Second Hospital of Lanzhou University, Lanzhou, China.

Zitieren

APA

Su, N., Jiang, L., Wang, Y., Dong, Y., Yong, Y., Yang, K., & Gao, S. (2024). Expressions of type I-III interferons in Sjögren's syndrome and non-Sjögren's dry eye. Ophthalmic Research. https://doi.org/10.1159/000540295

Vancouver

Su N, Jiang L, Wang Y, Dong Y, Yong Y, Yang K, et al. Expressions of type I-III interferons in Sjögren's syndrome and non-Sjögren's dry eye. Ophthalmic Research. 2024. doi:10.1159/000540295

BibTeX
@article{Su2024,
  author = {Su, Nan and Jiang, Lei and Wang, Yanpeng and Dong, Yanping and Yong, Yanjuan and Yang, Kan and Gao, Shixiong},
  title = {Expressions of type I-III interferons in Sjögren's syndrome and non-Sjögren's dry eye},
  journal = {Ophthalmic Research},
  year = {2024},
  doi = {10.1159/000540295}
}
Kostenlos starten →